Quantcast
Channel: eStocksDaily» Vivus
Browsing latest articles
Browse All 10 View Live

Healthcare Sector Recap: Vivus Inc. (NASDAQ:VVUS) Falls as Loss Swells in 3Q...

Healthcare sector was able to eke out gains on Tuesday session with a positive change of 0.06% with having 14% of the companies below the 2% level and 53% falling in below +2%. Vivus Inc. (VVUS),...

View Article



Vivus (NASDAQ:VVUS) Tumbles to Record Low Level after Q3 Financial Results –...

The Mountain View, California-based VIVUS, Inc (NASDAQ:VVUS) moved down to its record low level since February after the corporation announced a bigger than analysts forecasted loss in third-quarter...

View Article

Image may be NSFW.
Clik here to view.

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) Working on Restructuring Plan,...

BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX)has decided to lay off 50% of its labor force as an element of a reformation program focused at lowering costs while progressing its antiviral program and its...

View Article

Healthcare Stocks Roundup; Pfizer (NYSE:PFE) Lifts Dividend while Tranzyme...

On Monday, investors responded positively to the healthcare stocks. Key movement were observed in VIVUS, Inc (NASDAQ:VVUS) and Oncolytics Biotech, Inc (USA) (NASDAQ:ONCY) on percentage gainers side...

View Article

Eli Lilly & Co. (NYSE:LLY) Pays Charges Over Bribery Issues – LLY, GSK, PFE,...

Pharmaceutical company Eli Lilly & Co. (NYSE:LLY) was fined by the Securities and Exchange Commission because of violating the Foreign Corrupt Practices Act for inappropriate payments its...

View Article


Coronado Biosciences (NASDAQ:CNDO) Picks Harlan Weisman as New Chairman and...

Coronado Biosciences Inc (NASDAQ:CNDO) reported on Wednesday that the company has appointed Harlan Weisman as its new chairman and chief executive officer. Harlan Weisman recently worked for Johnson...

View Article

Salix Pharmaceuticals Ltd.’s (NASDAQ:SLXP) Gets FDA Approval for Fulyzaq –...

The Food and Drug Administration has accepted the initial anti-diarrheal drug for HIV/AIDS patients, Salix Pharmaceuticals Ltd.’s (NASDAQ:SLXP) Fulyzaq. The medicine, also called as crofelemer, is...

View Article

Healthcare Sector Under Scrutiny; Questcor Pharmaceuticals (QCOR) Inks Deal...

Investors reacted positively to the healthcare stocks on Wednesday. Key movement were seen in SIGA Technologies, Inc (NASDAQ:SIGA) and Dendreon Corporation (NASDAQ:DNDN) on percentage gainers side...

View Article


Emergent Biosolutions (NYSE:EBS) Issues FY 2012 Results; Revenue Misses...

Emergent BiosolutionsInc (NYSE:EBS) on Monday reported its preliminary fiscal year 2012 financial results, projecting revenues slightly lower than Wall Street analysts’ forecasts. Biopharmaceutical...

View Article


Illumina Inc. (NASDAQ:ILMN) Down to Knees after Roche Offer Refused – ILMN,...

Illumina Inc. (NASDAQ:ILMN)plunged almost 8.5% in premarket session on Monday following Roche Holding AG Chairman Franz Humer reported in an interview that the firm does not intend to purchase the gene...

View Article
Browsing latest articles
Browse All 10 View Live




Latest Images